Reserpine inhibition of coronary arteriosclerosis.

O. Carrier,B. Clower,P. Whittington-Coleman
DOI: https://doi.org/10.1139/Y69-017
Canadian Journal of Physiology and Pharmacology
Abstract:A histological study of rabbit hearts from animals on a high-cholesterol diet (2% by weight) supplemented with vasopressin administration (2–4 units, three times a week) showed that after 7 weeks this regimen caused coronary arteriosclerotic lesions in three out of five animals. At the end of 10 weeks, 95% of the coronary arteries observed in five out of five animals had signs of arteriosclerosis. When, in addition to this treatment, the rabbits received 0.1 mg/kg reserpine per day, the incidence and severity of the lesions were greatly reduced. At 7 weeks only 10%, and at 10 weeks only 26% of the coronary arteries observed showed arteriosclerotic changes. These data indicate that reserpine has a protective action against atheromatous lesions which may be associated with its calcium-depleting effect.
What problem does this paper attempt to address?